ImmunoPrecise Antibodies Ltd. (HYFT) Stock Analysis

Sector: NONE - NONE

Exchange: NASDAQ

Key Metrics

• Price: $1.19
• Market Cap: $58.36M
• EPS: $-0.58
• 52-Week High: $3.25
• 52-Week Low: $0.27

About ImmunoPrecise Antibodies Ltd.

MindWalk Holdings Corp., headquartered in Austin, Texas, is a pioneering biotechnology company specializing in the development of innovative immunotherapies and antibody solutions. With a strong emphasis on precision and efficacy, the firm aims to enhance treatment options for a range of diseases through advanced research and cutting-edge technology. By leveraging its expertise in monoclonal antibodies, MindWalk is positioned to make significant contributions to the healthcare sector, address...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for ImmunoPrecise Antibodies Ltd. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does HYFT pay dividends?

ImmunoPrecise Antibodies Ltd. (HYFT) does not currently pay a regular dividend.

What is HYFT's market cap?

ImmunoPrecise Antibodies Ltd. (HYFT) has a market capitalization of $58.36M with a current stock price of $1.19.